Replies to post #69953 on Innovation Pharmaceuticals Inc (IPIX)

[JUST 10-11-12]

WOW

[djs7]

Replaying some old company news (may have some relevance):

According to the American Podiatric Medical Association, a chronic diabetic foot wound occurs in approximately 15 percent of people with diabetes. Of those patients, up to 18 - 24 percent will require an amputation. Cellceutix believes the market size for an effective treatment is significantly larger than the ABSSSI market that alone is greater than a billion dollars in the U.S., thus the Company is targeting a potential multibillion-dollar worldwide market.

[DoubleJ23]

BK - I really like you numbers here. I try and keep realistic expectations regarding each of these indications and most of these numbers are on par to my own estimates.

But, I was wondering about your diabetic foot ulcer market estimate. It's hard to estimate the market potential for this one... I have trouble speculating how this one would be less than a billion dollar market...

is your number conservative or do you have a rationale here...?